Literature DB >> 16603643

Antimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniae.

Hyun-Joo Kim, Min-Jeong Seol, Hee-Soo Park, Dong-Rak Choi, Seung-Kyoo Seong, Hyun-Kil Shin, Jin-Hwan Kwak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16603643     DOI： 10.1093/jac/dkl144

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  1 in total

1.  Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.

Authors:  Chin Kook Rhee; Jung Hyun Chang; Eu Gene Choi; Hyun Kuk Kim; Yong-Soo Kwon; Sun Young Kyung; Ji-Hyun Lee; Myung Jae Park; Kwang Ha Yoo; Yeon Mok Oh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.